Toronto Dominion Bank
LGND icon

Toronto Dominion Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Toronto Dominion Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$862K Buy
+2,728
New +$643K ﹤0.01% 1431
2022
Q1 		– Sell
-14,070
Closed -$1.36M – 1734
2021
Q4 		$1.36M Buy
+14,070
New +$1.3M ﹤0.01% 945

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank's LGND Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 2,728 shares worth $862K. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in LGND as recently as Q4 2021.

Toronto Dominion Bank first reported a position in LGND in Q4 2021 and has held it in 2 quarters since. The position peaked at $1.36M in Q4 2021. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Toronto Dominion Bank held 2,728 shares of Ligand Pharmaceuticals worth $862K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Toronto Dominion Bank position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1431 holding.
  • Toronto Dominion Bank first reported a position in Ligand Pharmaceuticals in Q4 2021 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Ligand Pharmaceuticals position peaked at $1.36M in Q4 2021.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.